Delva P. Deauna-Limayo

Hematology
6900 N Pecos Rd
North Las Vegas, NV 89086

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis.

Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis.

Journal: Cancer medicine
Published: May 29, 2020

CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.

CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.

Journal: European journal of haematology
Published: January 06, 2014

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.

Journal: Blood
Published: January 02, 2014

Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.

Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 06, 2013

Kaposi sarcoma after non-myeloablative hematopoietic stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood human herpesvirus-8 reverse transcriptase-polymerase chain reaction levels.

Kaposi sarcoma after non-myeloablative hematopoietic stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood human herpesvirus-8 reverse transcriptase-polymerase chain reaction levels.

Journal: Leukemia & lymphoma
Published: January 25, 2013
Showing 1-5 of 5

Last Updated: 09/26/2026